Nvidia Partners with Bristol Myers, Nebius for AI Advancements
Nvidia partners with Bristol Myers Squibb to build an AI factory for drug discovery. A partnership between Nvidia and Palantir aims to help government agencies build secure AI systems. Nvidia also disclosed a 9.3% stake in Nebius.
Nvidia Corporation has partnered with Bristol Myers Squibb to develop an AI factory for drug discovery. This marks a significant investment in expanding the potential for drug development through artificial intelligence .
In other news, Nvidia has expanded its AI growth strategy with a new partnership with Palantir to assist government agencies in building secure, sovereign AI systems .
Further, Nvidia announced a notable investment by acquiring a 9.3% stake in Nebius , contributing to a significant increase in Nebius stock.
Bristol Myers Squibb is also using Nvidia technology to enhance its AI infrastructure for drug discovery, aiming to significantly boost capacity.
Related Stocks
Powered by SentiSense - Intelligent Market Analysis